Variables Associated With Risk of HCC: Univariate Analysis
| Variable . | Patients Who Developed HCC (n = 6) . | Patients Who Did Not Develop HCC (n = 379) . | P . |
|---|---|---|---|
| Age (yr) | 61 (45-70) | 31 (10-81) | <.0001 |
| Cirrhosis | 6 (100%) | 34 (9%) | <.0001 |
| Baseline AFP (ng/mL) | 25 (7-42) | 4 (1-88) | <.03 |
| Months of infection | 250 (156-336) | 239 (120-588) | <.7 |
| Anti-HIV | 1 (16%) | 140 (37%) | <.3 |
| Hemophilia | |||
| A | 4 (67%) | 307 (81%) | |
| B | 1 (16%) | 59 (16%) | <.2 |
| vWd | 1 (16%) | 13 (3%) |
| Variable . | Patients Who Developed HCC (n = 6) . | Patients Who Did Not Develop HCC (n = 379) . | P . |
|---|---|---|---|
| Age (yr) | 61 (45-70) | 31 (10-81) | <.0001 |
| Cirrhosis | 6 (100%) | 34 (9%) | <.0001 |
| Baseline AFP (ng/mL) | 25 (7-42) | 4 (1-88) | <.03 |
| Months of infection | 250 (156-336) | 239 (120-588) | <.7 |
| Anti-HIV | 1 (16%) | 140 (37%) | <.3 |
| Hemophilia | |||
| A | 4 (67%) | 307 (81%) | |
| B | 1 (16%) | 59 (16%) | <.2 |
| vWd | 1 (16%) | 13 (3%) |